Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hoffmann

Showing results (171-180 of 312) with videos related to

Pageof 32
Sort By:
The Lancet. Infectious Diseases|January 11, 2024
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in GermanyAnne Cossmann, Markus Hoffmann, Metodi V Stankov, et al.
The Lancet. Infectious Diseases|September 28, 2024
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccinationChristine Happle, Markus Hoffmann, Amy Kempf, et al.
Journal of the American Chemical Society|July 6, 2017
Electronic Delocalization in the Radical Cations of Porphyrin Oligomer Molecular WiresMartin D Peeks, Claudia E Tait, Patrik Neuhaus, et al.
Clinical and Translational Radiation Oncology|May 19, 2023
The impact of palliative radiotherapy on health-related quality of life in patients with head and neck cancer - Results of a multicenter prospective cohort studyMarie-Luise Weiss, Justus Domschikowski, David Krug, et al.
Plos Pathogens|May 10, 2011
Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell linesAnne Frentzen, Kathrin Hüging, Julia Bitzegeio, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
Nature Communications|July 29, 2025
Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitorKatarina Elez, Tim Hempel, Jonathan H Shrimp, et al.
Bioinformatics Advances|July 24, 2023
circRNA-sponging: a pipeline for extensive analysis of circRNA expression and their role in miRNA spongingMarkus Hoffmann, Leon Schwartz, Octavia-Andreea Ciora, et al.
Journal of Virology|November 16, 2018
Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat CellsMarkus Hoffmann, Inga Nehlmeier, Constantin Brinkmann, et al.
Oral Oncology|June 29, 2012
HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcomeSilke Tribius, Anna S Hoffmann, Sophie Bastrop, et al.
Pageof 32

Showing results (171-180 of 312) with videos related to

Sort By:
Pageof 32
The Lancet. Infectious Diseases|January 11, 2024
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in GermanyAnne Cossmann, Markus Hoffmann, Metodi V Stankov, et al.
The Lancet. Infectious Diseases|September 28, 2024
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccinationChristine Happle, Markus Hoffmann, Amy Kempf, et al.
Journal of the American Chemical Society|July 6, 2017
Electronic Delocalization in the Radical Cations of Porphyrin Oligomer Molecular WiresMartin D Peeks, Claudia E Tait, Patrik Neuhaus, et al.
Clinical and Translational Radiation Oncology|May 19, 2023
The impact of palliative radiotherapy on health-related quality of life in patients with head and neck cancer - Results of a multicenter prospective cohort studyMarie-Luise Weiss, Justus Domschikowski, David Krug, et al.
Plos Pathogens|May 10, 2011
Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell linesAnne Frentzen, Kathrin Hüging, Julia Bitzegeio, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
Nature Communications|July 29, 2025
Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitorKatarina Elez, Tim Hempel, Jonathan H Shrimp, et al.
Bioinformatics Advances|July 24, 2023
circRNA-sponging: a pipeline for extensive analysis of circRNA expression and their role in miRNA spongingMarkus Hoffmann, Leon Schwartz, Octavia-Andreea Ciora, et al.
Journal of Virology|November 16, 2018
Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat CellsMarkus Hoffmann, Inga Nehlmeier, Constantin Brinkmann, et al.
Oral Oncology|June 29, 2012
HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcomeSilke Tribius, Anna S Hoffmann, Sophie Bastrop, et al.
Pageof 32